Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcus Biosciences (RCUS) Equity Income (2018 - 2020)

Historic Equity Income for Arcus Biosciences (RCUS) over the last 3 years, with Q4 2020 value amounting to $1.2 million.

  • Arcus Biosciences' Equity Income changed N/A to $1.2 million in Q4 2020 from the same period last year, while for Jun 2021 it was $1.2 million, marking a year-over-year increase of 22639.18%. This contributed to the annual value of $613000.0 for FY2020, which is 15099.83% up from last year.
  • As of Q4 2020, Arcus Biosciences' Equity Income stood at $1.2 million.
  • Over the past 5 years, Arcus Biosciences' Equity Income peaked at $1.2 million during Q4 2020, and registered a low of -$482000.0 during Q1 2020.
  • Over the past 3 years, Arcus Biosciences' median Equity Income value was -$274500.0 (recorded in 2018), while the average stood at -$147300.0.
  • Per our database at Business Quant, Arcus Biosciences' Equity Income crashed by 17284.77% in 2019 and then surged by 6820.39% in 2020.
  • Quarter analysis of 3 years shows Arcus Biosciences' Equity Income stood at -$323000.0 in 2018, then dropped by 10.53% to -$357000.0 in 2019, then surged by 443.42% to $1.2 million in 2020.
  • Its Equity Income was $1.2 million in Q4 2020, compared to -$131000.0 in Q2 2020 and -$482000.0 in Q1 2020.